Malignant hyperthermia (MH) is a fulminant pharmacogenetic disorder in which the vast majority of identified causative mutations are found in the genes encoding RyR1 [8, 9] or CaV1.1 [10–13]. This evidence concerns the gene RYR1 and Malignant hyperthermia.